February 1, 2026February 2, 2026norcoviewerLeave a Comment on Lehigh Valley Stocks Year to Date, and a Quick Look at the Big Lilly News Lehigh Valley Stocks Year to Date, and a Quick Look at the Big Lilly News
January 30, 2026norcoviewerLeave a Comment on Jefferson Health Makes Agreement to Expand Use of AI Jefferson Health Makes Agreement to Expand Use of AI
December 1, 2025December 1, 2025norcoviewer1 Comment on City of Bethlehem May Vote to Pay for `Strategic Plan’ for Health Bureau at Tuesday’s Meeting City of Bethlehem May Vote to Pay for `Strategic Plan’ for Health Bureau at Tuesday’s Meeting
September 25, 2025norcoviewerLeave a Comment on Utz to Eliminate Use of `Food, Drug and Cosmetic’ Colors From Products by End of 2027 Utz to Eliminate Use of `Food, Drug and Cosmetic’ Colors From Products by End of 2027
September 24, 2025norcoviewerLeave a Comment on Jefferson Health, Operator of LVHN, to Use AI for Administrative Work Jefferson Health, Operator of LVHN, to Use AI for Administrative Work
July 27, 2025July 27, 2025norcoviewerLeave a Comment on Allentown’s Bradbury-Sullivan LGBT Center Says It Lost Pennie Contract, Has Cut Staff; Seeks Donations Allentown’s Bradbury-Sullivan LGBT Center Says It Lost Pennie Contract, Has Cut Staff; Seeks Donations
July 10, 2025July 10, 2025norcoviewerLeave a Comment on OraSure Adds Blood-Collection Device to Product Line OraSure Adds Blood-Collection Device to Product Line
July 7, 2025norcoviewerLeave a Comment on Aqueous Health Invests in Bethlehem Township-Based Principle Diagnostics; Strategy Is Similar to OraSure’s Approach Aqueous Health Invests in Bethlehem Township-Based Principle Diagnostics; Strategy Is Similar to OraSure’s Approach
May 14, 2025May 14, 2025norcoviewerLeave a Comment on OraSure, Targeted Genomics Collaborate on At-Home Celiac Genetic Testing OraSure, Targeted Genomics Collaborate on At-Home Celiac Genetic Testing
January 30, 2025norcoviewerLeave a Comment on Thermo Fisher Reports 4Q Revenue of $11.4 Billion, Adjusted EPS of $6.10 Thermo Fisher Reports 4Q Revenue of $11.4 Billion, Adjusted EPS of $6.10